The Impact of Chloroprocaine 3% for Ambulatory Foot Surgery on Perioperative Process Costs

NCT02406703 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-03-11

No results posted yet for this study

Summary

Background and Objectives Short acting regional anesthetics have already been successfully employed for peripheral nerve blocks in an ambulatory surgery setting. However, the impact on direct and indirect perioperative costs comparing two different short-acting local anesthetics has not been performed, yet.

Methods In an observational study including 50 patients per group, patient undergoing popliteal block with chloroprocaine 3% or mepivacaine 1.5% for ambulatory minor foot surgery were compared. The primary outcome was the saving of both direct and indirect perioperative costs. Secondary outcomes were block success, onset time and block duration, patient satisfaction and unplanned outpatient visits or readmissions after discharge.

Conditions

  • Impact of Anesthetic Choice on Costs

Interventions

DRUG

Chloroprocaine

DRUG

Mepivacaine

Sponsors & Collaborators

  • Ospedale Regionale Bellinzona e Valli

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-04-30
Completion
2014-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02406703 on ClinicalTrials.gov